Assessment of seizure liability in human iPSC-derived neurons using AI-HESI NeuTox Pilot study-

DOI Web Site Open Access
  • Matsuda Naoki
    Department of electronics,Tohoku Institute of Technology
  • Odawara Aoi
    Department of electronics,Tohoku Institute of Technology AIMR, Tohoku Univ. Japan Society for the Promotion of Science
  • Suzuki Ikuro
    Department of electronics,Tohoku Institute of Technology Consortium for Safety Assessment using Human iPS Cells Health and Environmental Sciences Institute (HESI) Japan Agency of Medical Research and Development

Bibliographic Information

Other Title
  • In vitro ヒトiPS細胞由来ニューロンを用いたAIによる痙攣毒性予測-HESI NeuTox Pilot study-

Description

<p>Micro-electrode array (MEA) assay using human iPSC-derived neurons are expected to one of in vitro assays to predict the toxicity and predict the mechanism of action of drugs. MEA subteam of NeuTox Committee in Health and Environmental Science Institute (HESI) have started the pilot study for the prediction of seizure liability of drugs. In this study, we aimed to develop an analytical method enabling the evaluation of toxicity of convulsants using deep learning. Human iPSC-derived cortical neurons and astrocytes were cultured on 24-wells MEA plate for extracellular recording using MED64 Presto. HESI twelve compounds were tested at 5 concentrations for each compound (n&gt;6). We firstly had artificial intelligence (AI) learned the data of convulsants and the data of non-convulsants. Next this AI predicted the Toxicity of the data not used for learning. The toxicity probability of unlearned sample data was 90% or more, and the toxicity probability of the unlearned convulsants was also 80% or more. In addition, the negative probability of non-convulsants was more than 80%. These results indicated that this AI analysis method is useful for predicting the convulsion toxicity using hiPSC-derived neurons.</p>

Journal

Details 詳細情報について

Report a problem

Back to top